$B9V1i(B $B;~9o(B | $B9V1i(B $BHV9f(B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $BJ,N`(B | $BHV9f(B $B | |
---|---|---|---|---|---|
Z$B2q>l(B $BBh(B3$BF|(B | |||||
(9:20$B!A(B10:00)$B!!(B($B;J2q(B $B8eF#2m9((B) | |||||
Z302 | [$BE8K>9V1i(B]$B$,$s:YK&$X$NHyN3;R$NI=LL?FOB@-$H%5%$%:8z2L(B | Cell adhesion up-take or endocytosis | S-28 | 1142 | |
(10:00$B!A(B10:20)$B!!(B($B:BD9(B $BD9Eo519T(B) | |||||
Z304 | [$BE8K>9V1i(B] $B!!0eLtMQ%"%_%N;@@=B$$K$*$1$k5;=Q3+H/%K!<%:$K$D$$$F(B | amino acid purification fermentation | S-28 | 1141 | |
(10:20$B!A(B11:00)$B!!(B($B;J2q(B $BFbEDGn5W(B) | |||||
Z305 | [$BE8K>9V1i(B]API$B@=B$%W%m%;%9$K$*$1$k>=@O9)Dx$N2]Bj(B | crystallization scale up active pharmaceutical | S-28 | 1143 | |
(11:00$B!A(B11:40)$B!!(B($B;J2q(B $B0KF# | |||||
Z307 | [$BE8K>9V1i(B]$B!!7k>=B?7A!&5 | Crystallization Polymorphism Crystallizer | S-28 | 1133 | |
(13:00$B!A(B13:40)$B!!(B($B;J2q(B $B>e%N;3<~(B) | |||||
Z313 | [$BE8K>9V1i(B]$B@=Lt!&@=:^%W%m%;%9$X$N%7%_%e%l!<%7%g%s5;=Q$NE,MQ(B | CFD Scale-up Optimization | S-28 | 824 | |
(13:40$B!A(B14:20)$B!!(B($B;J2q(B $BLJLn(B $BE/(B) | |||||
Z315 | [$BE8K>9V1i(B] $BHyN3;R%3!<%F%#%s%0!&%^%$%/%m%+%W%;%k2=%W%m%;%9(B-$BJ.N.AX%9%W%l! | Microgranulation Encapsulation Spouted bed spray-process | S-28 | 1140 | |
(14:20$B!A(B15:00)$B!!(B($B;J2q(B $B@nEg2EL@(B) | |||||
Z317 | [$BE8K>9V1i(B]$B!!@=:^%W%m%;%9$N%P%j%G!<%7%g%s$H:#8e$NF08~(B | validation PAT ICHQ8 | S-28 | 1137 | |
(15:00$B!A(B15:40)$B!!(B($B;J2q(B $B?yK\=SFsO:(B) | |||||
Z319 | [$BE8K>9V1i(B]$B!!0eLtIJ$NIJ | process analytical technology quality assurance physicochemical characterization | S-28 | 1139 | |
(15:40$B!A(B16:20)$B!!(B($B;J2q(B $B@nEg2EL@(B) | |||||
_ |